The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Acetaminophen, Guaifenesin, Dextromethorphan HBr, Phenylephrine HCl
Acetaminophen, Guaifenesin, Dextromethorphan HBr, Phenylephrine HCl · ACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 · Capsule, Liquid Filled · Oral · Opmx Llc
NDC 69729-0782-10 · 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl (oral solid) in the next 90 days
price up 11% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Opioid Analgesic REMS Shared System REMS
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Acetaminophen, Guaifenesin, Dextromethorphan HBr, Phenylephrine HCl (Capsule, Liquid Filled)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Opmx Llc | ACETAMINOPHEN 325 mg/1; GUAIFENESIN 200 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Opmx Llc | ACETAMINOPHEN 325 mg/1; GUAIFENESIN 10 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Opmx Llc | ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1; GUAIFENESIN 200 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Acetaminophen, Guaifenesin, Dextromethorphan HBr, Phenylephrine HCl — NDC 69729-0782-10," retrieved September 3, 2026, https://drugdashboards.com/drug/69729078210.
Free to cite with attribution — see how the data is put together.